Consulter en ligne

Suggestions

Du même auteur

Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis

Archive ouverte | Kastritis, Efstathios | CCSD

International audience. Oral melphalan and dexamethasone (MDex) were considered a standard of care in light-chain (AL) amyloidosis. In the past decade, bortezomib has been increasingly used in combination with alkyl...

Reply to S. Girnius et al.

Archive ouverte | Palladini, Giovanni | CCSD

International audience

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.

Archive ouverte | Palladini, Giovanni | CCSD

International audience. PURPOSE: To identify the criteria for hematologic and cardiac response to treatment in immunoglobulin light chain (AL) amyloidosis based on survival analysis of a large patient population. PA...

Chargement des enrichissements...